Re: Dugel et al: HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration (Ophthalmology. 2019 Apr 12 [Epub ahead of print])
Articolo
Data di Pubblicazione:
2019
Citazione:
Re: Dugel et al: HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration (Ophthalmology. 2019 Apr 12 [Epub ahead of print]) / Sharma, A.; Kumar, N.; Bandello, F.. - In: OPHTHALMOLOGY. - ISSN 0161-6420. - 126:12(2019), pp. e95-e96. [Epub ahead of print] [10.1016/j.ophtha.2019.08.017]
Tipologia CRIS:
1.1.1 Articolo in rivista - Review
Keywords:
Animals; Antibodies, Monoclonal, Humanized; Visual Acuity; Hawks; Macular Degeneration
Elenco autori:
Sharma, A.; Kumar, N.; Bandello, F.
Link alla scheda completa:
Pubblicato in: